Spruce Biosciences to Participate in the Jefferies Global Healthcare Conference

Rhea-AI Summary

Spruce Biosciences, a late-stage biopharmaceutical company specializing in therapies for rare endocrine disorders, will participate in the Jefferies Global Healthcare Conference.

CEO Javier Szwarcberg will present on June 5, 2024, at 5:00 p.m. ET.

The presentation will be accessible via a live webcast, with an archived version available for 90 days on the company's investor relations website.

Positive

• Participation in the Jefferies Global Healthcare Conference boosts visibility among investors and industry experts.
• CEO Javier Szwarcberg's presentation can increase investor confidence and interest.

Negative

• No immediate financial data or clinical trial updates provided, which might not satisfy investors looking for concrete progress.
• Potentially low impact on stock price if no significant new information is disclosed.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that Javier Szwarcberg, M.D., M.P.H., Chief Executive Officer, will present at the Jefferies Global Healthcare Conference on June 5, 2024, at 5:00 p.m. ET.

Interested parties can access the live webcast here. An archived copy of the webcast will be available on the events section of the company’s investor relations website for approximately 90 days.

About Spruce Biosciences

Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. Spruce is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal, once-daily therapy for patients suffering from classic congenital adrenal hyperplasia (CAH) and other endocrine disorders. To learn more, visit www.sprucebio.com and follow us on X, LinkedIn, Facebook, and YouTube.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240522135392/en/

Media Contact

Katie Beach Oltsik

Inizio Evoke Comms

(937) 232-4889

Katherine.Beach@inizioevoke.com

media@sprucebio.com

Investors

Samir Gharib

President and CFO

Spruce Biosciences, Inc.

investors@sprucebio.com

Source: Spruce Biosciences, Inc.

FAQ

What will Spruce Biosciences present at the Jefferies Global Healthcare Conference?

CEO Javier Szwarcberg will present at the Jefferies Global Healthcare Conference on June 5, 2024, at 5:00 p.m. ET.

How can I access Spruce Biosciences' presentation at the Jefferies Global Healthcare Conference?

The presentation will be accessible via a live webcast, and an archived copy will be available on the company's investor relations website for 90 days.

When is the Jefferies Global Healthcare Conference presentation by Spruce Biosciences?

The presentation is scheduled for June 5, 2024, at 5:00 p.m. ET.